Ani Pharmaceuticals (ANIP) Prepaid Assets (2010 - 2026)

Ani Pharmaceuticals has disclosed Prepaid Assets across 17 years of filings, most recently posting $31.9 million for Q2 2026.

• In Q2 2026, Prepaid Assets rose 111.4% year-over-year to $31.9 million; the TTM figure through Jun 2026 stood at $31.9 million (up 111.4% YoY), while the FY2025 annual figure was $34.2 million, up 90.35% from the prior year.
• Prepaid Assets came in at $31.9 million for Q2 2026 at Ani Pharmaceuticals, up from $22.1 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $34.2 million in Q4 2025 to a low of $5.0 million in Q3 2022.
• Average Prepaid Assets over 5 years is $15.6 million, with a median of $15.6 million recorded in 2024.
• Year-over-year, Prepaid Assets retreated 11.03% in 2023 and soared 133.49% in 2024.
• Over 5 years, Prepaid Assets stood at $8.4 million in 2022, then jumped by 107.46% to $17.4 million in 2023, then gained by 3.3% to $18.0 million in 2024, then soared by 90.35% to $34.2 million in 2025, then fell by 6.65% to $31.9 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $31.9 million in Q2 2026, $22.1 million in Q1 2026, and $34.2 million in Q4 2025.